Combined use of trazodone-naltrexone versus clonidine-naltrexone in rapid withdrawal from methadone treatment. A comparative inpatient study

Drug and Alcohol Dependence

Volumn 59, Issue 3, 2000, Pages 287-294

  Pozzi, Gino ^a   Conte, Gianluigi ^a   De Risio, Sergio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Clonidine; Naltrexone; Opiate withdrawal; Trazodone

Indexed keywords

CLONIDINE; METHADONE; NALTREXONE; OPIATE DERIVATIVE; TRAZODONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; METHADONE TREATMENT; OPIATE ADDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC ALPHA-AGONISTS; ADULT; ANALYSIS OF VARIANCE; CLONIDINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; OPIOID-RELATED DISORDERS; SEROTONIN UPTAKE INHIBITORS; STATISTICS, NONPARAMETRIC; SUBSTANCE WITHDRAWAL SYNDROME; TRAZODONE;

EID: 0034212175     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(99)00125-8     Document Type: Article

References (47)

1. Aghajanian G.K. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature. 276:1978;186-188.
2. Akaoka H., Aston-Jones G. Indirect serotonergic agonists attenuate neuronal opiate withdrawal. Neuroscience. 54:1993;561-565.
3. Ansseau M., DeRoeck J. Trazodone in benzodiazepine dependence. J. Clin. Psychiatry. 54:1993;189-191.
4. Bearn J., Gossop M., Strang J. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification. Drug Alcohol Depend. 50:1988;227-232.
5. Boccafusco J.J., Marshall D.C., Turner R.M. A comparison of the inhibitory effects of clonidine and guanfacine on the behavioural and autonomic components of morphine withdrawal in rats. Life Sci. 35:1984;1401-1408.
6. Brewerton T.D., Murphy D.L., Mueller E.A., Jimerson D.C. The induction of migraine-like headaches by the serotonin agonist m-chlorophenylpiperazine. Clin. Pharmacol. Ther. 43:1988;605-609.
7. Brodgen R.N., Heel R.C., Speight T.M., Avery G.S. Trazodone. A review of its pharmacological properties and therapeutic use in depression and anxiety. Drugs. 21:1981;401-476.
8. Bruno F., Ferracuti F. Terapia antagonista dell'eroino-dipendenza: esperienze di ricerca clinica [Antagonist Therapy of Heroin Dependence: Experiences of Clinical Research]. 1983;Centro Scientifico Torinese, Turin.
9. Charney D.S., Sternberg D.E., Kleber H.D. et al. The clinical use of clonidine in abrupt withdrawal from methadone. Arch. Gen. Psychiatry. 38:1981;1273-1277.
10. Charney D.S., Heninger G.R., Kleber H.D. The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone. Am. J. Psychiatry. 143:1986;831-837.
11. Conte G.L., Favazzo R., Pozzi G., Tempesta E. L'induzione al mantenimento con naltrexone: problemi clinici nell'accesso alla fase riabilitativa [The induction to naltrexone maintenance: clinical problems while entering rehabilitation]. Proceedings of the 2nd National Congress of the Italian Society for Psychosocial Rehabilitation in Psychiatry, Idelson, Naples. 1990;565-570.
12. Position statement on methadone maintenance treatment. Am. J. Psychiatry. 151:1994;792-796.
13. Dixon W.J. BMDP. Biomedical Computer Programs, Los Angeles. 1988.
14. Fedeli S., Ferri F.A., Fogari R. Blockage of acute opiate-withdrawal symptoms by trazodone treatment. Boll. Chim. Farmaceut. 118:1979;368-372.
15. Ghodse H., Myles J., Smith S.E. Clonidine is not a useful adjunct to methadone gradual detoxification in opioid addiction. Br. J. Psychiatry. 165:1994;370-374.
16. Gold M.S., Redmond D.E., Kleber H.D. Clonidine blocks acute opiate-withdrawal symptoms. Lancet. 2(8090):1978;599-602.
17. Gold M.S. Opiate addiction and the locus coeruleus: the clinical utility of clonidine, naltrexone, methadone and buprenorphine. Psychiat. Clin. North Am. 16:1993;61-73.
18. Gossop M., Strang B. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification. Br. J. Psychiatry. 158:1991;679-679.
19. Gossop M., Bradley B., Phillips G.T. An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day inpatient methadone detoxification procedure. Addict. Behav. 12:1987;1-6.
20. Gossop M. Clonidine and the treatment of the opiate withdrawal syndrome. Drug Alcohol Depend. 21:1988;253-259.
21. Haria M., Fitton A., McTavish D. Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging. 4:1994;331-355.
22. Janiri L., Mannelli P., Persico A.M. et al. Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine. Drug Alcohol Depend. 36:1994;139-145.
23. Janiri L., Hadjichristos A., Buonanno A. et al. Adjuvant trazodone in the treatment of alcoholism: an open study. Alcohol Alcoholism. 33:1998;362-365.
24. Jasinski D.R., Johnson R.E., Kocher T.R. Clonidine in morphine withdrawal. Differential effects on signs and symptoms. Arch. Gen. Psychiatry. 42:1985;1063-1066.
25. Kahn A., Mumford J.P., Ash Rogers G., Beckford H. Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital. Drug Alcohol Depend. 44:1997;57-61.
26. Kanof P.D., Aronson M.J., Ness R. Organic mood syndrome associated with detoxification from methadone maintenance. Am. J. Psychiatry. 150:1993;423-428.
27. Marek G.J., McDougle C.J., Price L.H., Seiden L.S. A comparison of trazodone and fluoxetine: implications for serotonergic mechanism of antidepressant action. Psychopharmacology. 109:1992;2-11.
28. O'Connor P.G., Kosten T.R. Rapid and ultrarapid opioid detoxification techniques. J. Am. Med. Assoc. 279(3):1988;229-234.
29. Otani K., Tanaka O., Kaneko S. et al. Mechanisms of the development of trazodone withdrawal symptoms. Int. Clin. Psychopharmacol. 9:1994;131-133.
30. Pinelli A., Trivulzio S., Spezia R. Effects of tizanidine administration on precipitated opioid withdrawal signs in rats. Drug Alcohol Depend. 50:1998;81-88.
31. Price L.H., Charney D.S., Heninger G.R. Effect of trazodone treatment on alpha-2 adrenoceptor function in depressed patients. Psychopharmacology. 89:1986;38-44.
32. Riblet L.A., Taylor D.P. Pharmacology and neurochemistry of trazodone. J. Clin. Psychopharmacol. 1(Suppl):1981;17-22.
33. Richelson E., Nelson A. Antagonism by antidepressants of neurotrasmitter receptors of normal human brain in vitro. J. Pharmacol. Exp. Ther. 230:1984;94-102.
34. Richelson E. The pharmacology of three serotonin-selective drugs. Ann. Clin. Psychiatry. 2:1990;157-164.
35. Rickels K., Schweizer E., Garcia Espana F. et al. Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome. Psychopharmacology. 141:1999;1-5.
36. Roccatagliata G., Albano C., Maffini M., Farelli S. Alcohol withdrawal syndrome treatment with trazodone. Int. Pharmacopsychiatry. 15:1980;105-110.
37. Romandini S., Cervo L., Samanin R. Evidence that drugs increasing 5-hydroxytryptamine transmission block jumping but not wet-dog shakes in morphine-abstinent rats: a comparison with clonidine. J. Pharm. Pharmacol. 36:1984;68-70.
38. Rotzinger S., Fang J., Baker G.B. Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources. Drug Metab. Dispos. 26:1998;572-575.
39. Schubert H., Fleischhacker W.W., Meise U., Theohar C. Preliminary results of guanfacine treatment of acute opiate withdrawal. Am. J. Psychiatry. 141:1984;1271-1273.
40. Shearman G.T., Lal H., Ursillo R.C. Effectiveness of lofexidine in blocking morphine-withdrawal signs in rats. Pharmacol. Biochem. Behav. 12:1980;573-575.
41. Silvestrini B., Valeri P. A comparative and pharmacological study of trazodone and dapiprazole. Biggio G. et al. Modulation of Central and Peripheral Transmitter Function. 1986;435-442 Springer, Berlin.
42. Small G.W., Purcell J.J. Trazodone and cocaine abuse. Arch. Gen. Psychiatry. 42:1985;524.
43. Taylor D.P., Hyslop D.K., Riblet L.A. Trazodone, a new non-tricyclic antidepressant without anticholinergic activity. Biochem. Pharmacol. 29:1980;2149-2150.
44. Valeri P., Palmery M., Silvestrini B. Binding profile of trazodone and dapiprazole to some brain receptors. Drugs Exp. Clin. Res. 14:1988;53-58.
45. Valeri P., Martinelli B., Pimpinella G., Severini C. Effects of dapiprazole, clonidine and yohimbine on development of dependence and withdrawal behaviour in mice. Drug Alcohol Depend. 23:1989;73-77.
46. Valeri P., Pimpinella G., Morrone L.A., Romanelli L. Antinociceptive effects of trazodone and m-chlorophenylpiperazine in mice: interaction with morphine. Gen. Pharmacol. 22:1991;127-131.
47. Valeri P., Pimpinella G., Troiani M.P. et al. Effects of trazodone and m-clorophenylpiperazine on acute dependence in mice. Brain Res. Bull. 26:1991;799-802.